Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.
Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.
Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.
American Shared Hospital Services (AMS) announced its Q1 2024 financial results, highlighting a record projected revenue backlog of $210 million following the acquisition of Rhode Island Radiation Therapy Cancer Centers. Total revenue for Q1 reached $5.2 million, a 5.9% increase year-over-year, with proton beam radiation therapy revenue up by 14.5%. Gamma Knife revenue slightly decreased by 1.7%. Gross margin improved by 12.3% to $2.1 million. However, operating loss stood at $85,000 compared to a $98,000 operating income in Q1 2023, mainly due to $377,000 in acquisition-related fees. Adjusted EBITDA was $1.74 million, down from $1.90 million the previous year. Cash reserves decreased to $13.04 million from $13.80 million at the end of 2023. Despite increased selling and administrative costs, AMS remains optimistic about future growth driven by new international and domestic centers.
American Shared Hospital Services (AMS) has acquired a 60% majority interest in three radiation therapy cancer centers in Rhode Island, adding $9-$10 million in annual revenue with a positive net income contribution. The acquisition more than doubles the revenue backlog to over $210 million, expanding the company's U.S. footprint and product offering.
American Shared Hospital Services (AMS) will hold a conference call to discuss its first quarter 2024 financial results on May 14th. Investors can dial in or join the webcast to get insights into the Company's performance.
FAQ
What is the current stock price of Amer Shared Hosp (AMS)?
What is the market cap of Amer Shared Hosp (AMS)?
